# Ziconotide Effectiveness and Safety Trial in Patients With Chronic Severe Pain

> **NCT00076544** · PHASE3 · COMPLETED · sponsor: **Elan Pharmaceuticals** · enrollment: 300 (—)

## Conditions studied

- Pain

## Interventions

- **DRUG:** Ziconotide

## Key facts

- **NCT ID:** NCT00076544
- **Lead sponsor:** Elan Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-02
- **Primary completion:** 2005-03
- **Final completion:** —
- **Target enrollment:** 300 (—)
- **Last updated:** 2015-12-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00076544

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00076544, "Ziconotide Effectiveness and Safety Trial in Patients With Chronic Severe Pain". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00076544. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*